Financhill
Back

Ligand Pharmaceuticals Vs. Evolution AB Industry Stock Comparison

Sell
48

LGND
Ligand Pharmaceuticals

Last Price:
$113.45
Seasonality Move:
9.17%
Sell
30

EVVTY
Evolution AB

Last Price:
$75.37
Seasonality Move:
18.13%
Sell
48
Ligand Pharmaceuticals (LGND) is a Sell

Is Ligand Pharmaceuticals a Buy, Sell or Hold?

  • The current Ligand Pharmaceuticals [LGND] share price is $113.38. The Score for LGND is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • LGND is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Evolution AB (EVVTY) is a Sell

Is Evolution AB a Buy, Sell or Hold?

  • The current Evolution AB [EVVTY] share price is $75.55. The Score for EVVTY is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • EVVTY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

LGND Stock Price Chart

What is Ligand Pharmaceuticals's stock price today?

  • The Ligand Pharmaceuticals share price today is $113.38
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LGND is experiencing slight buying pressure.

EVVTY Stock Price Chart

What is Evolution AB's stock price today?

  • The Evolution AB share price today is $75.55
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EVVTY is experiencing buying pressure, which is a positive indicator for future bullish movement.

LGND Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.5 Sell
Relative Strength Index (14 RSI): 44.98 Sell
Chaikin Money Flow: 4519 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (114.3 - 122.38) Sell
Bollinger Bands (100): (100.62 - 116.98) Buy

EVVTY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.31 Sell
Relative Strength Index (14 RSI): 22.57 Sell
Chaikin Money Flow: 70854 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (81.79 - 90.17) Sell
Bollinger Bands (100): (87.54 - 99.86) Sell

LGND Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 116.22 Sell
20-day SMA: 118.94 Sell
50-day SMA: 115.44 Sell
200-day SMA: 95.77 Buy
8-day EMA: 115.5 Sell
20-day EMA: 116.95 Sell
50-day EMA: 114.67 Sell
200-day EMA: 99.24 Buy

EVVTY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 80.93 Sell
20-day SMA: 85.1 Sell
50-day SMA: 89.23 Sell
200-day SMA: 102.86 Sell
8-day EMA: 80.29 Sell
20-day EMA: 84.05 Sell
50-day EMA: 88.47 Sell
200-day EMA: 99.3 Sell

Ligand Pharmaceuticals Earnings Growth & LGND Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.31 per share, and an increase next year of $0.48 per share.

Evolution AB Earnings Growth & EVVTY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Ligand Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Evolution AB Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):